T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFSI
1276
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $12.5M | ﹤0.01% |
382,986
+41,400
| +12% | +$1.25M |
|
1277
Generac Holdings
GNRC
$12.8B
| $12.5M | ﹤0.01% |
314,785
-9,980
| -3% | -$431K |
|
1278
ACI Worldwide
ACIW
$5.42B
| $12.5M | ﹤0.01% |
508,900
+477,700
| +1,531% | +$11.2M |
|
1279
Globe Life
GL
$14B
| $12.5M | ﹤0.01% |
214,616
+4,900
| +2% | +$280K |
|
|
TSS
1280
DELISTED
Total System Services, Inc.
TSS
| $12.5M | ﹤0.01% |
298,978
+21,700
| +8% | +$877K |
|
|
BLOX
1281
DELISTED
Infoblox Inc
BLOX
| $12.5M | ﹤0.01% |
476,060
-800
| -0.2% | -$20.2K |
|
1282
Diageo
DEO
$52.8B
| $12.4M | ﹤0.01% |
106,785
+7,500
| +8% | +$853K |
|
1283
Williams-Sonoma
WSM
$28.5B
| $12.4M | ﹤0.01% |
301,200
+10,800
| +4% | +$422K |
|
1284
Pultegroup
PHM
$24.9B
| $12.3M | ﹤0.01% |
612,112
+5,400
| +0.9% | +$110K |
|
1285
Chemed
CHE
$7.02B
| $12.3M | ﹤0.01% |
93,700
+39,600
| +73% | +$4.9M |
|
|
RSPP
1286
DELISTED
RSP Permian, Inc.
RSPP
| $12.2M | ﹤0.01% |
435,240
+8,700
| +2% | +$248K |
|
|
AXE
1287
DELISTED
Anixter International Inc
AXE
| $12.2M | ﹤0.01% |
187,000
-16,900
| -8% | -$1.2M |
|
1288
Leggett & Platt
LEG
$1.32B
| $12.2M | ﹤0.01% |
249,846
-100
| -0% | -$4.67K |
|
1289
Perdoceo Education
PRDO
$1.99B
| $12.1M | ﹤0.01% |
3,665,380
+1,020,270
| +39% | +$4.31M |
|
|
ZOES
1290
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $12.1M | ﹤0.01% |
295,100
+164,000
| +125% | +$5.72M |
|
|
ABMD
1291
DELISTED
Abiomed Inc
ABMD
| $12.1M | ﹤0.01% |
183,650
+170,350
| +1,281% | +$11.3M |
|
|
CBM
1292
DELISTED
Cambrex Corporation
CBM
| $12.1M | ﹤0.01% |
274,610
+80,600
| +42% | +$3.34M |
|
|
KW
1293
DELISTED
Kennedy-Wilson Holdings
KW
| $12.1M | ﹤0.01% |
490,443
+24,200
| +5% | +$619K |
|
|
YELL
1294
DELISTED
Yellow Corporation Common Stock
YELL
| $12M | ﹤0.01% |
926,670
+90,700
| +11% | +$1.35M |
|
|
XTLY
1295
DELISTED
Xactly Corporation
XTLY
| $12M | ﹤0.01% |
+1,400,000
| New | +$12.1M |
|
1296
RE/MAX Holdings
RMAX
$265M
| $11.9M | ﹤0.01% |
335,620
+200
| +0.1% | +$6.8K |
|
|
OXFD
1297
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $11.9M | ﹤0.01% |
859,900
+1,400
| +0.2% | +$18.9K |
|
1298
Oceaneering
OII
$5.11B
| $11.9M | ﹤0.01% |
255,278
-14,307
| -5% | -$752K |
|
1299
Lincoln Electric
LECO
$15.5B
| $11.9M | ﹤0.01% |
195,131
-18,389
| -9% | -$1.22M |
|
|
FCH
1300
DELISTED
Felcor Lodging Trust
FCH
| $11.8M | ﹤0.01% |
1,199,248
+115,600
| +11% | +$1.26M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.